Evaluating the incidence and utility of microscopic metastatic dissemination as diagnosed by lumbar cerebro-spinal fluid (CSF) samples in children with newly diagnosed intracranial ependymoma

Jason Fangusaro, Clark Van Den Berghe, Tadanori Tomita, Veena Rajaram, Dolly Aguilera, Deli Wang, Stewart Goldman

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Ependymomas are the third most common central nervous system (CNS) tumor in childhood. After resection, the standard evaluation of intracranial ependymomas includes a post-contrast spine MRI and a lumbar CSF sample to evaluate for metastasis. Although it is estimated that 10-30% of patients will present with metastatic disease, it is unclear what percentage of metastatic disease is solely identified microscopically via lumbar cytology versus that identified as bulky disease on post-contrast spinal MRIs. We retrospectively evaluated all patients at our institution with intracranial ependymoma diagnosed between January 1991 and June 2008 in an effort to evaluate prognostic factors, survival outcomes and incidence of metastatic disease. Sixty-one evaluable patients were identified: 46% were male and the mean age at diagnosis was 64 months (2.04-196.92). The most common tumor location was the posterior fossa (77%) and 64% of patients achieved a gross total resection with initial surgery. Five-year event-free and overall survivals were 39 ± 7% and 87 ± 4%, respectively. Approximately 10% of patients presented with bulky metastatic disease as seen on post-contrast spine MRI. No patient whose spine MRI was negative for tumor had positive lumbar CSF cytology. These data highlight the rarity of patients who present with microscopic metastatic disease noted on lumbar cytology alone and suggest that evaluation of lumbar cytology may not be useful in patients with negative post-contrast spine MRIs. Future prospective trials may be helpful in validating this conclusion before eliminating this procedure as part of the standard evaluation in newly diagnosed ependymoma patients.

Original languageEnglish (US)
Pages (from-to)693-698
Number of pages6
JournalJournal of Neuro-Oncology
Volume103
Issue number3
DOIs
StatePublished - Jul 2011

Fingerprint

Ependymoma
Cerebrospinal Fluid
Incidence
Cell Biology
Spine
Central Nervous System Neoplasms
Disease-Free Survival
Neoplasms
Neoplasm Metastasis
Survival

Keywords

  • Cerebro-spinal fluid (CSF)
  • Ependymoma
  • Metastases
  • Pediatric

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neurology

Cite this

Evaluating the incidence and utility of microscopic metastatic dissemination as diagnosed by lumbar cerebro-spinal fluid (CSF) samples in children with newly diagnosed intracranial ependymoma. / Fangusaro, Jason; Van Den Berghe, Clark; Tomita, Tadanori; Rajaram, Veena; Aguilera, Dolly; Wang, Deli; Goldman, Stewart.

In: Journal of Neuro-Oncology, Vol. 103, No. 3, 07.2011, p. 693-698.

Research output: Contribution to journalArticle

Fangusaro, Jason ; Van Den Berghe, Clark ; Tomita, Tadanori ; Rajaram, Veena ; Aguilera, Dolly ; Wang, Deli ; Goldman, Stewart. / Evaluating the incidence and utility of microscopic metastatic dissemination as diagnosed by lumbar cerebro-spinal fluid (CSF) samples in children with newly diagnosed intracranial ependymoma. In: Journal of Neuro-Oncology. 2011 ; Vol. 103, No. 3. pp. 693-698.
@article{afb3a4d91ed347ec96da7af35d99f7d7,
title = "Evaluating the incidence and utility of microscopic metastatic dissemination as diagnosed by lumbar cerebro-spinal fluid (CSF) samples in children with newly diagnosed intracranial ependymoma",
abstract = "Ependymomas are the third most common central nervous system (CNS) tumor in childhood. After resection, the standard evaluation of intracranial ependymomas includes a post-contrast spine MRI and a lumbar CSF sample to evaluate for metastasis. Although it is estimated that 10-30{\%} of patients will present with metastatic disease, it is unclear what percentage of metastatic disease is solely identified microscopically via lumbar cytology versus that identified as bulky disease on post-contrast spinal MRIs. We retrospectively evaluated all patients at our institution with intracranial ependymoma diagnosed between January 1991 and June 2008 in an effort to evaluate prognostic factors, survival outcomes and incidence of metastatic disease. Sixty-one evaluable patients were identified: 46{\%} were male and the mean age at diagnosis was 64 months (2.04-196.92). The most common tumor location was the posterior fossa (77{\%}) and 64{\%} of patients achieved a gross total resection with initial surgery. Five-year event-free and overall survivals were 39 ± 7{\%} and 87 ± 4{\%}, respectively. Approximately 10{\%} of patients presented with bulky metastatic disease as seen on post-contrast spine MRI. No patient whose spine MRI was negative for tumor had positive lumbar CSF cytology. These data highlight the rarity of patients who present with microscopic metastatic disease noted on lumbar cytology alone and suggest that evaluation of lumbar cytology may not be useful in patients with negative post-contrast spine MRIs. Future prospective trials may be helpful in validating this conclusion before eliminating this procedure as part of the standard evaluation in newly diagnosed ependymoma patients.",
keywords = "Cerebro-spinal fluid (CSF), Ependymoma, Metastases, Pediatric",
author = "Jason Fangusaro and {Van Den Berghe}, Clark and Tadanori Tomita and Veena Rajaram and Dolly Aguilera and Deli Wang and Stewart Goldman",
year = "2011",
month = "7",
doi = "10.1007/s11060-010-0448-6",
language = "English (US)",
volume = "103",
pages = "693--698",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "3",

}

TY - JOUR

T1 - Evaluating the incidence and utility of microscopic metastatic dissemination as diagnosed by lumbar cerebro-spinal fluid (CSF) samples in children with newly diagnosed intracranial ependymoma

AU - Fangusaro, Jason

AU - Van Den Berghe, Clark

AU - Tomita, Tadanori

AU - Rajaram, Veena

AU - Aguilera, Dolly

AU - Wang, Deli

AU - Goldman, Stewart

PY - 2011/7

Y1 - 2011/7

N2 - Ependymomas are the third most common central nervous system (CNS) tumor in childhood. After resection, the standard evaluation of intracranial ependymomas includes a post-contrast spine MRI and a lumbar CSF sample to evaluate for metastasis. Although it is estimated that 10-30% of patients will present with metastatic disease, it is unclear what percentage of metastatic disease is solely identified microscopically via lumbar cytology versus that identified as bulky disease on post-contrast spinal MRIs. We retrospectively evaluated all patients at our institution with intracranial ependymoma diagnosed between January 1991 and June 2008 in an effort to evaluate prognostic factors, survival outcomes and incidence of metastatic disease. Sixty-one evaluable patients were identified: 46% were male and the mean age at diagnosis was 64 months (2.04-196.92). The most common tumor location was the posterior fossa (77%) and 64% of patients achieved a gross total resection with initial surgery. Five-year event-free and overall survivals were 39 ± 7% and 87 ± 4%, respectively. Approximately 10% of patients presented with bulky metastatic disease as seen on post-contrast spine MRI. No patient whose spine MRI was negative for tumor had positive lumbar CSF cytology. These data highlight the rarity of patients who present with microscopic metastatic disease noted on lumbar cytology alone and suggest that evaluation of lumbar cytology may not be useful in patients with negative post-contrast spine MRIs. Future prospective trials may be helpful in validating this conclusion before eliminating this procedure as part of the standard evaluation in newly diagnosed ependymoma patients.

AB - Ependymomas are the third most common central nervous system (CNS) tumor in childhood. After resection, the standard evaluation of intracranial ependymomas includes a post-contrast spine MRI and a lumbar CSF sample to evaluate for metastasis. Although it is estimated that 10-30% of patients will present with metastatic disease, it is unclear what percentage of metastatic disease is solely identified microscopically via lumbar cytology versus that identified as bulky disease on post-contrast spinal MRIs. We retrospectively evaluated all patients at our institution with intracranial ependymoma diagnosed between January 1991 and June 2008 in an effort to evaluate prognostic factors, survival outcomes and incidence of metastatic disease. Sixty-one evaluable patients were identified: 46% were male and the mean age at diagnosis was 64 months (2.04-196.92). The most common tumor location was the posterior fossa (77%) and 64% of patients achieved a gross total resection with initial surgery. Five-year event-free and overall survivals were 39 ± 7% and 87 ± 4%, respectively. Approximately 10% of patients presented with bulky metastatic disease as seen on post-contrast spine MRI. No patient whose spine MRI was negative for tumor had positive lumbar CSF cytology. These data highlight the rarity of patients who present with microscopic metastatic disease noted on lumbar cytology alone and suggest that evaluation of lumbar cytology may not be useful in patients with negative post-contrast spine MRIs. Future prospective trials may be helpful in validating this conclusion before eliminating this procedure as part of the standard evaluation in newly diagnosed ependymoma patients.

KW - Cerebro-spinal fluid (CSF)

KW - Ependymoma

KW - Metastases

KW - Pediatric

UR - http://www.scopus.com/inward/record.url?scp=79959811440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959811440&partnerID=8YFLogxK

U2 - 10.1007/s11060-010-0448-6

DO - 10.1007/s11060-010-0448-6

M3 - Article

C2 - 21038109

AN - SCOPUS:79959811440

VL - 103

SP - 693

EP - 698

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 3

ER -